Back to Results
First PageMeta Content
Medicine / MRI contrast agent / Nephrogenic systemic fibrosis / Gadolinium / Magnetic resonance imaging / Renal failure / Gadoversetamide / Chemistry / Nephrology / Matter


OptiMARK™ 0.5 mmol/mL (Gadoversetamide Injection) PRESCRIBING INFORMATION Rx only Mallinckrodt Inc. May 2013
Add to Reading List

Document Date: 2013-05-23 16:04:28

Open Document

File Size: 293,89 KB

Share Result on Facebook
UPDATE